Your session is about to expire
← Back to Search
Other
APAP and NAC combination for Fever
N/A
Waitlist Available
Led By Matthew Chang, MD
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 hours after study drug administration
Awards & highlights
Study Summary
The purpose of this study is to compare the efficacy of the an N-acetyl-p-aminophenol (APAP, also known as acetaminophen) and N-acetylcysteine (NAC) combination versus an APAP-placebo combination as an anti-pyretic agent.
Eligible Conditions
- Fever
- Liver Injury
- Prevention and Control
- Liver Failure
- Acute Liver Failure
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 hours after study drug administration
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 hours after study drug administration
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Difference in temperature reduction between participants who are administered combination N-acetyl-p-aminophenol and N-Acetylcysteine (APAP-NAC) versus combination APAP-placebo
Secondary outcome measures
Difference in liver function tests after study drug administration between participants who are administered combination N-acetyl-p-aminophenol and N-Acetylcysteine (APAP-NAC) versus combination APAP-placebo
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: APAP and NAC combinationExperimental Treatment1 Intervention
N-acetyl-p-aminophenol and placebo (APAP-NAC) combination pill
Group II: APAP and Placebo combinationPlacebo Group1 Intervention
N-acetyl-p-aminophenol and placebo (APAP-placebo) combination pill
Find a Location
Who is running the clinical trial?
Columbia UniversityLead Sponsor
1,448 Previous Clinical Trials
2,531,490 Total Patients Enrolled
5 Trials studying Fever
2,087 Patients Enrolled for Fever
Matthew Chang, MDPrincipal InvestigatorColumbia University
Share this study with friends
Copy Link
Messenger